Loading resource…
Mayo Clinic, Takeda Pharmaceuticals, Banner Sun Health Research Institute, U.S. Food and Drug Administration, The Michael J. Fox Foundation, Novartis, Lund University, University of California Berkeley, Washington University St. Louis School of Medicine,
The document outlines updated diagnostic criteria for Alzheimer's disease, emphasizing the importance of biomarker profiles in defining the disease. It discusses the evolution of these criteria in light of new research and the need for a biological definition of Alzheimer's, distinguishing it from mere symptomatic descriptions. The article also details the classification of biomarkers and their relevance in clinical practice, aiming to improve diagnostic accuracy and patient management.
No account needed